SGSM3 Activators encompass a diverse array of chemical compounds that indirectly bolster the functional activity of SGSM3 through modulation of specific signaling pathways. Forskolin, IBMX, and 8-Bromo-cAMP all amplify intracellular cAMP levels, which can activate protein kinase A (PKA). PKA, in turn, is known to phosphorylate various substrates that may be involved in the signaling pathways that SGSM3 modulates, particularly those linked to intracellular trafficking and vesicle movement. Similarly, PMA, through activation of PKC, and Bisindolylmaleimide I, by its inhibition of PKC, may influence SGSM3 activity by modifying the phosphorylation status of proteins within SGSM3-related signaling pathways. This modulation potentially affects the intricate processes of membrane dynamics and cargo sorting in which SGSM3 is implicated. Moreover, Ionomycin and A23187, both acting as calcium ionophores, could lead to the activation of calcium-dependent proteins and enhance SGSM3 signaling capabilities by influencing pathways dependent on calcium signaling.
Furthermore, U0126 serves as an inhibitor for MEK1/2, altering the associated AKT and ERK signaling pathways. Epigallocatechin gallate (EGCG), with its protein kinase inhibitory properties, might recalibrate signaling pathways to favor those regulated by SGSM3, enhancing its role in cellular signaling networks. Sphingosine-1-phosphate activates its cognate receptors and could potentiate SGSM3's role in signaling pathways that oversee intracellular trafficking, a key aspect of SGSM3's functionality. Rolipram, by preventing phosphodiesterase 4 activity, also raises cAMP levels, thereby amplifying PKA activity which could have downstream effects on SGSM3's activity within its signaling milieu. Collectively, these activators operate through distinct but interrelated mechanisms, converging on the enhancement of SGSM3's activity within its native signaling pathways, thus bolstering the protein's intrinsic functional capacity without affecting its expression levels directly.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin increases intracellular cAMP, which in turn can activate PKA. PKA phosphorylation events can enhance the functional activity of SGSM3 by activating pathways SGSM3 is involved in, particularly those related to intracellular trafficking. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-specific inhibitor of phosphodiesterases, leading to an increase in cAMP levels. Elevated cAMP could enhance SGSM3 activity by stimulating signaling cascades that SGSM3 modulates. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can phosphorylate proteins within signaling pathways that SGSM3 is a part of, potentially enhancing its activity related to membrane dynamics. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, possibly leading to the activation of calcium-dependent proteins that interact with SGSM3, enhancing its signaling capabilities. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromo-cAMP is a cell-permeable cAMP analog that activates PKA. PKA can modify the activity of proteins and signaling pathways associated with SGSM3, thus enhancing its functional role. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram inhibits phosphodiesterase 4, leading to increased cAMP levels, and subsequent PKA activation. This can enhance SGSM3 activity indirectly through PKA's role in signaling pathways that SGSM3 is involved in. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a known inhibitor of various protein kinases, which can alter multiple signaling pathways. This may lead to an indirect enhancement of SGSM3 activity by shifting the balance of signaling towards pathways that SGSM3 regulates. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate activates sphingosine-1-phosphate receptors, potentially enhancing SGSM3 activity by influencing signaling pathways that regulate intracellular trafficking, where SGSM3 is active. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I is a specific PKC inhibitor that can modulate PKC activity, potentially enhancing SGSM3 signaling pathways by affecting the phosphorylation status of proteins within those pathways. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore similar to Ionomycin and can increase intracellular calcium, which can lead to activation of SGSM3 through calcium-dependent signaling pathways. | ||||||